137 Cancer Drugs to Get Cheaper as NPPA Caps Trade Margins at 30%
The NPPA has capped trade margins on 137 non-scheduled anti-cancer drugs at 30%, with revised maximum retail prices expected to take effect November 9.
The NPPA has capped trade margins on 137 non-scheduled anti-cancer drugs at 30%, with revised maximum retail prices expected to take effect November 9.